BioReference Laboratories, Inc.'s (BRLI) second-quarter net income after taxes rose to $11.34 million, or $0.41 a share, from $9.31 million, or $0.33 a share, as adjusted for Topic 954, last year. On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.41 for the quarter. Analysts' estimates typically exclude one-time items.
The company said it recorded quarterly revenues of $176.45 million, the highest recorded revenues in a quarter in corporate history, up 17% over the $151.44 million, as adjusted for Topic 954, recorded in the second quarter of fiscal 2012. Analysts estimated revenues of $176.04 million for the quarter.
For comments and feedback: editorial@rttnews.com